- Report
- March 2025
- 115 Pages
Global
From €4096EUR$4,650USD£3,600GBP
- Report
- December 2024
- 170 Pages
Global
From €5240EUR$5,950USD£4,606GBP
- Report
- April 2025
- 130 Pages
Global
From €4316EUR$4,900USD£3,794GBP
- Report
- March 2025
Global
From €4316EUR$4,900USD£3,794GBP
From €4316EUR$4,900USD£3,794GBP
- Report
- March 2025
- 120 Pages
Global
From €4316EUR$4,900USD£3,794GBP
- Report
- March 2025
- 115 Pages
Global
From €4316EUR$4,900USD£3,794GBP
- Report
- March 2025
Global
From €4316EUR$4,900USD£3,794GBP
- Report
- February 2025
- 287 Pages
Global
From €4844EUR$5,500USD£4,258GBP
- Report
- September 2025
- 137 Pages
Global
From €2245EUR$2,549USD£1,974GBP
€2641EUR$2,999USD£2,322GBP
- Report
- September 2025
- 147 Pages
Global
From €2245EUR$2,549USD£1,974GBP
€2641EUR$2,999USD£2,322GBP
- Report
- August 2025
- 136 Pages
Global
From €2245EUR$2,549USD£1,974GBP
€2641EUR$2,999USD£2,322GBP
- Report
- August 2025
- 139 Pages
Global
From €2245EUR$2,549USD£1,974GBP
€2641EUR$2,999USD£2,322GBP
- Report
- August 2025
- 149 Pages
Global
From €2245EUR$2,549USD£1,974GBP
€2641EUR$2,999USD£2,322GBP
- Report
- June 2025
- 135 Pages
Global
From €2245EUR$2,549USD£1,974GBP
€2641EUR$2,999USD£2,322GBP
- Report
- April 2025
- 145 Pages
Global
From €2245EUR$2,549USD£1,974GBP
€2641EUR$2,999USD£2,322GBP
- Report
- April 2025
- 138 Pages
Global
From €2245EUR$2,549USD£1,974GBP
€2641EUR$2,999USD£2,322GBP
- Report
- February 2025
- 150 Pages
Global
From €2245EUR$2,549USD£1,974GBP
€2641EUR$2,999USD£2,322GBP
- Report
- February 2025
- 147 Pages
Global
From €2245EUR$2,549USD£1,974GBP
€2641EUR$2,999USD£2,322GBP
- Report
- January 2025
- 136 Pages
Global
From €2245EUR$2,549USD£1,974GBP
€2641EUR$2,999USD£2,322GBP

The RNA market is a subset of the genomics market that focuses on the study of ribonucleic acid (RNA). RNA is a molecule that plays a key role in the regulation of gene expression and is involved in many cellular processes. It is used in a variety of applications, including diagnostics, therapeutics, and research.
The RNA market is expected to grow at a steady rate due to the increasing demand for RNA-based products and services. This growth is driven by advances in technology, such as next-generation sequencing, which has enabled the development of more accurate and cost-effective RNA-based products. Additionally, the increasing prevalence of chronic diseases and the need for personalized medicine are expected to drive the growth of the RNA market.
Companies in the RNA market include Illumina, Thermo Fisher Scientific, Qiagen, Agilent Technologies, Bio-Rad Laboratories, and F. Hoffmann-La Roche. Show Less Read more